UBITh AD immunotherapeutic vaccine (United Biomedical)

N/A

Report date: 2023/08/14 15:45:26

Base Information

Drug NameUBITh AD immunotherapeutic vaccine (United Biomedical)
Drug Alias NameUB-311
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulantsBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUnited Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnited Neuroscience LtdUnited Biomedical Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A